FDA Approved: DILANTIN — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for Dilantin (extended phenytoin sodium) by Viatris Specialty LLC. The approval concerns the extended formulation of phe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Status Epilepticus

Drugs mentioned

• DILANTIN (Phenytoin sodium, extended release)

Snippet

SUPPL AP for DILANTIN (EXTENDED PHENYTOIN SODIUM)